News

WHO Extended Global Emergency Status of MPox Epidemic – Development of Treatment for MPox with NV-387 is Timely, Says NanoViricides
SHELTON, CONNECTICUT / ACCESS Newswire / July 16, 2025 / NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) ...
New approach for testing multiple treatment combinations at once could aid in development of cancer drugs
MIT researchers have developed a new theoretical framework for studying the mechanisms of treatment interactions. Their ...